# John A. Blessing

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/john-a-blessing/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,434 |
| Field | Ovarian cancer diagnosis and treatment |
| h-index | 70 |
| i10-index | 199 |
| OpenAlex ID | https://openalex.org/A5111536542 |
| Works | 300 |

## Researcher papers

- [Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.](https://scholariq.org/papers/prolonged-oral-etoposide-as-second-line-therapy-for-platinum-resistant-and/)
- [Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study](https://scholariq.org/papers/fixed-dose-rate-gemcitabine-plus-docetaxel-as-second-line-therapy-for-metastatic/)

## Researcher topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Uterine Myomas and Treatments](https://scholariq.org/topics/uterine-myomas-and-treatments-2/)
- [Cervical Cancer and HPV Research](https://scholariq.org/topics/cervical-cancer-and-hpv-research/)
- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.